Mavacamten’s therapeutic impact: cardiac-specific myosin inhibition in obstructive hypertrophic cardiomyopathy
Dear Editor, Obstructive hypertrophic cardiomyopathy (oHCM) is a hereditary cardiac condition, affecting 1 in about 500 individuals, characterized by an atypical thickening of the heart muscle, specifically the interventricular septum...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
PAGEPress Publications
2024-11-01
|
| Colección: | Global Cardiology |
| Materias: | |
| Acceso en línea: | https://www.globalcardiology.info/site/article/view/48 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|